Review Article
Adenosine Receptors Modulate Acute Injury and Neuroinflammation in Brain Ischemia
Table 1
Adenosine A2A receptor ligands used in brain ischemia “in vivo” and “in vitro” models.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
APEC: 2-(2-aminoethylamino)-carbonylethylphenylethylamino-5′-N-ethylcarboxoamidoadenosine; CGS15943: 9-chloro-2-(2-furanyl)-1,2,4triazolo1,5-cquinazolin-5-amine; CGS21680: 2-p-(2-Carboxyethyl)phenethylamino-5′-N-ethylcarboxamidoadenosine; CP66713: 4-amino1,2,4triazolo4,3aquinoxalines; CSC: 8-(3-chlorostyryl)caffeine; DMPX: 3,7-dimethyl-1-propargylxanthine; OGD: oxygen and glucose deprivation; SCH58261: 7-(2-phenylethyl)-5-amino-2-(2-furyl)-pyrazolo-4,3-e-1,2,4triazolo1,5-cpyrimidine; ZM241385: 4-(2-7-amino-2-(2-furyl)1,2,4triazolo2,3-a1,3,5triazin-5-yl-amino]ethyl)phenol. |